CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Cardiovascular safety of liraglutide: Pooled analysis of Major adverse cardiovascular events across weight management and Type 2 Diabetes development programs
DOI 10.1055/s-0036-1580943
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Jacob, T Wehrhahn, I Caterson, S Bain, J Gross, J House, A Salisbury, S Marso, F Baeres, M Donsmark
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
A meta-analysis of five phase II/III liraglutide (up to 3.0 mg) weight management (WM) trials, additional sensitivity meta-analyses of 21 liraglutide type 2 diabetes (T2D) trials (up to 1.8 mg) and a pre-specified pooled analysis of WM+T2D trials (n = 27) were performed to assess liraglutide's cardiovascular safety in individuals with overweight/obesity and T2D. The primary endpoint was first occurrence of adjudicat…
Zitieren
Zitierempfehlung
S Jacob, T Wehrhahn, I Caterson, S Bain, J Gross, J House, A Salisbury, S Marso, F Baeres, M Donsmark (2016) Cardiovascular safety of liraglutide: Pooled analysis of Major adverse cardiovascular events across weight management and Type 2 Diabetes development programs. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0036-1580943
Mit CareLit weiterarbeiten